Wojciech Piotrowski

Associate Professor

Medical University of Lodz

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Wojciech Piotrowski is an Associate Professor at the Medical University of Lodz in Poland. His research primarily focuses on pulmonary diseases, with recent articles examining biomarkers in interstitial lung diseases, the role of fungal microbiota in COPD exacerbations, and treatment persistence in idiopathic pulmonary fibrosis. He has also contributed to studies on the impact of COVID-19 on sarcoidosis and the biological mechanisms underlying aging-related respiratory issues.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (24)

Adam Barczyk

Head of Department / Professor

Medical University of Silesia School of Medicine in Katowice

POLAND

Wojciech Piotrowski

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend

Serum KL-6 and SP-D: Markers of Lung Function in Autoimmune-Related Interstitial Lung Diseases

Sarcoidosis and COVID-19: a research letter unveiling our insights

Fungal microbiota in COPD patients during exacerbations

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland

Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study

The Short-Term Efficacy of a Three-Week Pulmonary Rehabilitation Program among Patients with Obstructive Lung Diseases

Unlocking Diagnostic Precision: FATE Protocol Integration with BLUE and eFAST Protocols for Enhanced Pre-Hospital Differential Diagnosis of Pleural Effusion Manifested as Dyspnea in Adults—A Pilot Study

Aging Lung: Molecular Drivers and Impact on Respiratory Diseases—A Narrative Clinical Review

Proteinoza pęcherzyków płucnych wstępnie błędnie rozpoznana jako zapalenie płuc w przebiegu COVID-19

Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?

A Real-World Multicenter Retrospective Observational Study on Polish Experience with Nintedanib Therapy in Patients with Idiopathic Pulmonary Fibrosis: The PolExNIB Study

Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single‐arm, open‐label nonrandomized study

Calcium, Phosphate, and Vitamin D Status in Patients with Sarcoidosis—Associations with Disease Activity and Symptoms

Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications

Oral Health and Wellbeing of Patients with Idiopathic Pulmonary Fibrosis

Soluble ITGaM and ITGb2 Integrin Subunits Are Involved in Long-Term Pulmonary Complications after COVID-19 Infection

Concise, Practical Review on Transthoracic Lung Ultrasound in Prehospital Diagnosis of Dyspnea in Adults

Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study

Ultrasound on the Frontlines: Empowering Paramedics with Lung Ultrasound for Dyspnea Diagnosis in Adults—A Pilot Study

Is Pulmonary Involvement a Distinct Phenotype of Post-COVID-19?

Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis

Study protocol for connective tissue disease-associated interstitial lung disease trial (TEL-CTD-ILD): A randomized controlled trial of a home-based telemonitoring of treatment effects

Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma

Collaborators (24)

Adam Barczyk

Paweł Majak

Szymon Skoczyński

Adam Stanczyk

Patrycja Rzepka-Wrona

Adam Bialas

Leszek Gottwald

Dariusz Ziora

Piotr Boros

Sebastian Kłosek

Katarzyna Górska

Rafal Krenke

Ewa Jassem

Michał Panek

Magdalena Martusewicz-Boros

Alicja Sieminska

Joanna Makowska

Oskar Rosiak

Łukasz Kuncman

Rafał Pawliczak

Sebastian Majewski

Tadeusz Pietras

Bogdan Batko

Paweł Górski

Make your next move.